enVVeno Medical Corp (NVNO)

3.15 +0.09 (+2.94%) USD  |  NASDAQ  |  Dec 27, 16:00
3.23 +0.08 (+2.54%) After-Hours: 20:00
More

enVVeno Medical Research and Development Expense (Quarterly): 2.859M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for NVNO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
NeuroOne Medical Technologies Corp 1.114M
SINTX Technologies Inc 0.796M
Nutriband Inc 0.8808M
Beyond Air Inc 4.585M
CVRx Inc 2.504M